tiletamine hydrochloride has been researched along with Insulinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, A; Kawai, T; Ogasawara, A; Saisho, Y; Simizu, S; Takei, I; Umezawa, K | 1 |
| Hirose, H; Horimai, C; Itoh, H; Miyashita, K; Saisho, Y; Takei, I; Umezawa, K | 1 |
2 other study(ies) available for tiletamine hydrochloride and Insulinoma
| Article | Year |
|---|---|
Inhibition of NO-induced β-cell death by novel NF-κB inhibitor (-)-DHMEQ via activation of Nrf2-ARE pathway.
Topics: Animals; Antioxidant Response Elements; Apoptosis; Benzamides; Cyclohexanones; Gene Knockdown Techniques; Insulin-Secreting Cells; Insulinoma; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Pancreatic Neoplasms; Signal Transduction; Tumor Cells, Cultured | 2013 |
Effects of DHMEQ, a novel nuclear factor-kappab inhibitor, on beta cell dysfunction in INS-1 cells.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Survival; Cyclohexanones; Dose-Response Relationship, Drug; Glucose; Insulin; Insulin-Secreting Cells; Insulinoma; NF-kappa B; Pancreatic Neoplasms; Rats; Tumor Necrosis Factor-alpha | 2008 |